Progress of Phototherapy Applications in the Treatment of Bone Cancer.
Jiachen SunFei XingJoy BraunFrank TraubPol Maria RommensZhou XiangUlrike RitzPublished in: International journal of molecular sciences (2021)
Bone cancer including primary bone cancer and metastatic bone cancer, remains a challenge claiming millions of lives and affecting the life quality of survivors. Conventional treatments of bone cancer include wide surgical resection, radiotherapy, and chemotherapy. However, some bone cancer cells may remain or recur in the local area after resection, some are highly resistant to chemotherapy, and some are insensitive to radiotherapy. Phototherapy (PT) including photodynamic therapy (PDT) and photothermal therapy (PTT), is a clinically approved, minimally invasive, and highly selective treatment, and has been widely reported for cancer therapy. Under the irradiation of light of a specific wavelength, the photosensitizer (PS) in PDT can cause the increase of intracellular ROS and the photothermal agent (PTA) in PTT can induce photothermal conversion, leading to the tumoricidal effects. In this review, the progress of PT applications in the treatment of bone cancer has been outlined and summarized, and some envisioned challenges and future perspectives have been mentioned. This review provides the current state of the art regarding PDT and PTT in bone cancer and inspiration for future studies on PT.
Keyphrases
- photodynamic therapy
- papillary thyroid
- bone mineral density
- squamous cell
- cancer therapy
- bone loss
- minimally invasive
- drug delivery
- lymph node metastasis
- bone regeneration
- childhood cancer
- young adults
- body composition
- dna damage
- radiation induced
- cell death
- replacement therapy
- smoking cessation
- current status
- drug release
- drug administration
- case control